Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Ziarco Pharma Ltd, a biopharmaceutical company focusing on steroid-unresponsive inflammation and allergic diseases, is pleased to announce this prestigious award of grant funding from the TSB.
read more
Hovione and Zerion Pharma A/S revealed an extension of their collaboration on Zerion's Dispersome® technology into the nutraceutical/diet supplements domain. Many dietary supplements suffer from low solubility.
read more
Yposkesi, a leading Contract Development and Manufacturing Organization (CDMO) specializing in cell and gene therapies, announced the launch of project SKY, the construction of Yposkesi’s second commercial cell and gene therapy facility and new ...
read more
Yposkesi announces the appointment of Morad El Gueddari as production director, gene therapy operations.
read more
Wednesday, October 19, 2022
Piramal Pharma Limited (PPL) announced that Yapan Bio has expanded its capabilities with a new process development facility at Genome Valley, Hyderabad, India.
read more
Thursday, September 12, 2013
Xcelience announced today the completion of a milestone 25 percent increase in staff since September of 2012, growing from 85 team members then to 113 today.
read more
Xcelience is proud to announce the grand opening of its new 71,000 square foot headquarters located at 4910 Savarese Circle in Tampa. The building houses preformulation and formulation development labs and suites, as well as analytical and stability...
read more
Thursday, November 28, 2013
Xcelience announced today the hiring of Joseph Iacobucci as Vice President of Clinical Supplies and Services. Mr. Iacobucci brings nearly 30 years of experience in clinical packaging and supply services, including 23 years as a Vice President for ...
read more
Tuesday, September 22, 2015
Xcelience and Powdersize announced today the addition of the Netzsch Delta Vita media mills, a nanoparticle milling solution, to their arsenal of capabilities. For the first time, one CDMO
can provide solutions for a full range of particle size ...
read more
X-Chem announced the establishment of a research partnership with Sironax, in which X-Chem will leverage its powerful DEL platform to support Sironax’s drug discovery pipeline.
read more
STA Pharmaceutical, a WuXi AppTec group company, has merged with WuXi AppTec’s Pharmaceutical Development Services division.
read more
Monday, December 09, 2019
WuXi Vaccines will invest 240 million USD and build a new vaccine manufacturing facility in Ireland.
read more
Wednesday, March 27, 2019
STA Pharmaceutical WuXi STA announces its new drug product manufacturing facility in Waigaoqiao Free Trade Zone of Shanghai has passed its first GMP inspection by the European MPA.
read more
STA Pharmaceutical announced its Jinshan manufacturing facility in Shanghai, China has successfully passed an inspection by the EMA with no critical and no major findings.
read more
Thursday, February 22, 2018
STA Pharmaceutical and Regulus Therapeutics have entered into an oligonucleotide synthesis collaboration agreement for research and mid-scale non-GMP/cGMP manufacturing.
read more